Physician profile
Steven Tanner
NPI 1114233996
$8,138.55
in general payments reported to CMS, 2019-2025
31 companies · $1,330 in 2025
The $1,330 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $84.27 · 2021: $74.62 · 2022: $5,904 · 2023: $314 · 2024: $227 · 2025: $1,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,116 · Food and Beverage: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,115.86 |
| Food and Beverage | $755.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,097.70 | 2022-2025 | |
| Acessa Health INC. | $738.21 | 2022 | |
| Mayne Pharma Commercial LLC | $234.67 | 2021-2025 | |
| Abbvie INC. | $159.13 | 2019-2022 | |
| Hologic Sales and Service, LLC | $102.55 | 2022-2024 | Acessa Provu System |
| Biogen, INC. | $75.67 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $58.81 | 2019-2025 | Sos |
| Shield Therapeutics INC | $58.34 | 2023-2024 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $56.43 | 2022-2025 | |
| Astellas Pharma US INC | $46.24 | 2023 | Veozah |
| Amag Pharmaceuticals, INC. | $41.33 | 2019-2020 | |
| Organon LLC | $40.57 | 2022-2024 | |
| Duchesnay USA Incorporated | $37.76 | 2019 | |
| Medtronic, INC. | $36.67 | 2022 | |
| Olympus America INC. | $35.82 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $34.19 | 2022-2025 | |
| Meditrina | $29.14 | 2022 | |
| Exeltis, USA INC. | $28.64 | 2021-2024 | Slynd |
| Millicent US INC | $24.04 | 2025 | Femlyv |
| Baxter Healthcare | $22.47 | 2024 | Tisseel |
| Monaghan Medical Corporation | $21.99 | 2024 | Aerochamber |
| Myovant Sciences INC. | $19.49 | 2022 | |
| Channel Medsystems, INC. | $17.76 | 2023 | |
| Gynesonics, INC. | $17.15 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Ethicon US, LLC | $16.80 | 2019 | |
| Exact Sciences Corporation | $16.51 | 2025 | Cologuard Collection Kit |
| Northgate Technologies, INC. | $16.18 | 2024 | Stimsite |
| Davol INC. | $15.44 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.90 | 2022 | |
| Lupin INC. | $12.07 | 2021 | |
| Aspira Women'S Health INC | $11.88 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Tanner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.